Skip to main content
Log in

Hochprozessierte Lebensmittel und Krebsrisiko

Ultra-processed food consumption and cancer risk

  • Journal Club
  • Published:
Die Onkologie Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Literatur

  1. World Health Organization (2020) WHO report on cancer: setting priorities, investing wisely and providing care for all

    Google Scholar 

  2. Bray F, Laversanne M, Weiderpass E, Soerjomataram I (2021) The ever-increasing importance of cancer as a leading cause of premature death worldwide. Cancer 127(16):3029–3030

    Article  PubMed  Google Scholar 

  3. World Cancer Research Fund, American Institute for Cancer Research (2018) Diet, nutrition, physical activity and cancer: a global perspective. Continuous Update Project Expert Report

    Google Scholar 

  4. Baudry J, Assmann KE, Touvier M, Allès B, Seconda L, Latino-Martel P, Ezzedine K, Galan P, Hercberg S, Lairon D, Kesse-Guyot E (2018) Association of frequency of organic food consumption with cancer risk: findings from the Nutrinet-Santé prospective cohort study. JAMA Intern Med 178(12):1597–1606. https://doi.org/10.1001/jamainternmed.2018.4357 (Erratum in: JAMA Intern Med. 2018 Dec 1;178(12):1732. PMID: 30422212; PMCID: PMC6583612)

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hakan Alakus.

Ethics declarations

Interessenkonflikt

J. Bochtler, M. Hartmann und H. Alakus geben an, dass kein Interessenkonflikt besteht.

Additional information

figure qr

QR-Code scannen & Beitrag online lesen

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bochtler, J., Hartmann, M. & Alakus, H. Hochprozessierte Lebensmittel und Krebsrisiko. Onkologie 29, 642–644 (2023). https://doi.org/10.1007/s00761-023-01356-3

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00761-023-01356-3

Navigation